LEUPROLIDE ACETATE SUSPENSION FO. Key specifications include part_name_assigned_by_controlling_agency: LEUPROLIDE ACETATE SUSPENSION FOR INJECTION PREFILLED SYRINGE 3.75MG MONTH/SINGLE USE, american_hospital_formulary_service_classification_number: 100000. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-506-2039, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | LEUPROLIDE ACETATE SUSPENSION FOR INJECTION PREFILLED SYRINGE 3.75MG MONTH/SINGLE USE |
| american_hospital_formulary_service_classification_number | 100000 |
| NSN | 6505-01-506-2039 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LEUPROLIDE ACETATE SUSPENSION FOR INJECTION PREFILLED SYRINGE 3.75MG MONTH/SINGLE USE |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 100000 |
| SPECIAL FEATURES | EACH SYRINGE CONTAINS STERILE LYOPHILIZED MICROSPHERES. WHEN MIXED WITH DILUENT BECOMES A SUSPENSION INTENDED AS A SINGLE MONTHLY INTRAMUSCULAR INJECTION. THE FRONT CHAMBER IS 3.75 MG LEUPROLIDE ACETATE, THE SECOND CHAMBER CONTAINS DILUENT; PREFILLED DUAL CHAMBER SYRINGE; PRESERVATIVE FREE; SINGLE USE, STORE AT 25 DEG C; FOR MANAGEMENT OF ENDOMETRIOSIS DEGC |